If you’re not familiar, microdosing psilocybin canada is a way to get the effects of psychedelics without taking them to “trip.” This means that you take very small doses of drugs like LSD or magic mushrooms to boost mental clarity and focus. It’s a way to use these powerful substances for good, and it could have big implications for the way we treat depression and anxiety.

A lawsuit filed in late July by a group called TheraPsil in Canada aims to make it easier for medical patients to access psilocybin, the active ingredient in magic mushrooms. It is not expected to go to trial for another year or so, but if it succeeds, it would force Canada to set up a legal framework for the drug—similar to what happened with marijuana—and possibly pave the way for more open access across North America and the world.

Magic in Every Dose: Buying Shrooms Online

Health Canada is aware of the growing interest in psilocybin, which occurs naturally in certain mushroom species1 (“magic mushrooms”), for potential therapeutic purposes. The agency is encouraging individuals to explore options available through clinical trials or Health Canada’s Special Access Program, which are existing regulatory pathways that may provide greater certainty of safety and quality for a drug used in a clinical setting.

Surveys have identified diverse motivations for microdosing, with a particular focus on addressing psychological distress and enhancing cognitive well-being and performance.3-4 Nonetheless, it is important to note that the current body of evidence regarding these benefits remains largely anecdotal, and further research is needed to confirm whether these changes are directly attributable to psilocybin or to other factors.